Showing results (1-10 of 4) with videos related to
Sort By:
Pageof 1
Expert Opinion on Drug Discovery|June 2, 2021
Artificial intelligence in early drug discovery enabling precision medicineFabio Boniolo, Emilio Dorigatti, Alexander J Ohnmacht, et al.International Journal of Molecular Sciences|September 28, 2021
Inferred Ancestral Origin of Cancer Cell Lines Associates with Differential Drug ResponsePhong B H Nguyen, Alexander J Ohnmacht, Samir Sharifli, et al.Nature Communications|September 4, 2023
The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancerAlexander J Ohnmacht, Arndt Stahler, Sebastian Stintzing, et al.European Journal of Cancer (Oxford, England : 1990)|April 3, 2025
FOLFIRI with cetuximab or bevacizumab in RAS wild-type metastatic colorectal cancer: Refining first-line treatment selection by combining clinical parameters: A post hoc analysis of the randomized open-label phase III trial FIRE-3/AIO KRK0306Julian Walter Holch, Alexander J Ohnmacht, Sebastian Stintzing, et al.Pageof 1